You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

c-MET

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Tumors Trial (ABN401)

Not yet recruiting
  • Neoplasms
  • (no location specified)
May 21, 2023

Solid Tumor Trial in Bengbu (SPH 3348)

Recruiting
  • Solid Tumor
  • SPH 3348
  • Bengbu, Anhui, China
    The First Affliated Hospital of Bengbu Medical College
Jul 25, 2022

Novel FLUorescENt C-mEt Tracer in Penile and Tongue

Completed
  • Head and Neck Cancer
  • Penile Cancer
    • Amsterdam, Noord-Holland, Netherlands
      The Netherlands Cancer Institute / Antoni van Leeuwenhoek
    Oct 18, 2022

    NSCLC Trial (Telisotuzumab Vedotin, Osimertinib, Cisplatin)

    Not yet recruiting
    • Non-Small Cell Lung Cancer
    • Telisotuzumab Vedotin
    • +4 more
    • (no location specified)
    Oct 17, 2023

    Advanced Solid Tumors Trial in Goyang-si, Seoul (ABN401)

    Not yet recruiting
    • Advanced Solid Tumors
    • Goyang-si, Gyeonggi-Do, Korea, Republic of
    • +2 more
    Sep 13, 2022

    Endometrial Cancer Recurrent Trial in Tainan (Crizotinib 250 MG)

    Recruiting
    • Endometrial Cancer Recurrent
    • Crizotinib 250 MG
    • Tainan, Taiwan
      National Cheng Kung University Hospital
    Jun 6, 2022

    Solid Tumor Trial in United States (TR1801-ADC)

    Active, not recruiting
    • Unspecified Adult Solid Tumor, Protocol Specific
    • TR1801-ADC
    • Los Angeles, California
    • +4 more
    Oct 30, 2022

    Patients With Solid Tumors, Either Refractory to Standard Therapy or for Which no Effective Standard Therapy is Available Trial

    Completed
    Has Results
    • Patients With Solid Tumors, Either Refractory to Standard Therapy or for Which no Effective Standard Therapy is Available
    • Houston, Texas
      M.D. Anderson Cancer Center
    Aug 22, 2022

    Colorectal Cancer Metastatic, C-met Overexpression Trial in Rozzano (Tivantinib (ARQ197))

    Completed
    • Colorectal Cancer Metastatic
    • C-met Overexpression
    • Tivantinib (ARQ197)
    • Rozzano, Milano, Italy
      Istituto Clinico Humanitas
    Sep 8, 2022

    Lung Non-Small Cell Carcinoma Trial (Amivantamab, Biospecimen Collection, Computed Tomography)

    Not yet recruiting
    • Lung Non-Small Cell Carcinoma
    • Amivantamab
    • +3 more
    • (no location specified)
    Oct 30, 2023

    Carcinoma, Hepatocellular Trial in Darmstadt (Tepotinib)

    Completed
    Has Results
    • Carcinoma, Hepatocellular
    • Darmstadt, Germany
      Please contact the Merck KGaA Communication Center located in
    Aug 22, 2022

    Posterior Brain Fossa Tumors in Children Trial in Bron (11C-MET PET/MRI)

    Completed
    • Posterior Brain Fossa Tumors in Children
    • 11C-MET PET/MRI
    • Bron, France
      Hospices Civils de Lyon - Groupement Hospitalier Est - Hôpital F
    Nov 29, 2021

    Digestive Cancer Trial (RC108)

    Not yet recruiting
    • Digestive Cancer
    • (no location specified)
    Nov 17, 2022

    Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial (procedure, biological, drug)

    Not yet recruiting
    • Recurrent Lung Non-Small Cell Carcinoma
    • Stage IV Lung Cancer AJCC v8
    • Biospecimen Collection
    • +5 more
    • (no location specified)
    Sep 7, 2023

    Recurrent Squamous Cell Lung Carcinoma, Stage IV Squamous Cell Lung Carcinoma AJCC V7 Trial in Houston (ABBV-399)

    Completed
    Has Results
    • Recurrent Squamous Cell Lung Carcinoma
    • Stage IV Squamous Cell Lung Carcinoma AJCC V7
    • Houston, Texas
      M D Anderson Cancer Center
    Sep 21, 2021

    Advanced Hepatocellular Carcinoma With c-MET Dysregulation Trial in Worldwide (INC280)

    Active, not recruiting
    • Advanced Hepatocellular Carcinoma With c-MET Dysregulation
    • Nanjing, Jiangsu, China
    • +7 more
    Jan 12, 2023

    Metastatic Breast Cancer, Breast Cancer Trial in Houston (Neratinib, Capmatinib)

    Not yet recruiting
    • Metastatic Breast Cancer
    • Breast Cancer
    • Houston, Texas
      M D Anderson Cancer Center
    Feb 16, 2022

    Solid Tumor Trial in Worldwide (BYON3521)

    Recruiting
    • Solid Tumor
    • Brussels, Belgium
    • +3 more
    Aug 2, 2022

    Tumor, Solid Tumors Trial in Camperdown, Liverpool (HS-10241)

    Completed
    • Neoplasm
    • Solid Tumors
    • Camperdown, New South Wales, Australia
    • +1 more
    Jul 18, 2022

    c-MET Expression and EGFR Gene Mutation Correlation With

    Completed
    • Non-small Cell Lung Cancer Metastatic
    • Non-small Cell Lung Cancer Recurrent
      • Hwasun, Korea, Republic of
        Chonnam National University Hwasun Hospital
      Aug 1, 2021

      Hepatic Impairment Trial in Miami, Orlando (Tepotinib)

      Completed
      • Hepatic Impairment
      • Miami, Florida
      • +1 more
      Aug 22, 2022

      Advanced Solid Tumors Trial in Australia, Korea, Republic of (ABN401- Escalation Phase, ABN401- Expansion Phase)

      Recruiting
      • Advanced Solid Tumors
      • ABN401- Escalation Phase
      • ABN401- Expansion Phase
      • Kogarah, New South Wales, Australia
      • +6 more
      May 2, 2022

      NSCLC?EGFR Sensitive Mutation Trial in Bengbu, Changsha, Shanghai (MCLA-129: 1500mg or 2000mg IV Q2W, Befotertinib: 75 mg or 100

      Not yet recruiting
      • Non-Small Cell Lung Cancer、EGFR Sensitive Mutation
      • MCLA-129: 1500mg or 2000mg IV Q2W
      • Befotertinib: 75 mg or 100 mg Po QD
      • Bengbu, Anhui, China
      • +2 more
      Aug 28, 2023

      NSCLC Trial in China (BPI-9016M)

      Recruiting
      • Non-small Cell Lung Cancer
      • Hefei, Anhui, China
      • +6 more
      Sep 5, 2021

      Lung Cancer Trial in Edinburgh (Optical Imaging Agents (EMI-137, NAP), Delivery Device Cathetar and Miniaturised imaging fibre,

      Recruiting
      • Lung Cancer
      • Optical Imaging Agents (EMI-137, NAP)
      • +2 more
      • Edinburgh, United Kingdom
        Royal Infirmary of Edinburgh
      Apr 27, 2021